nanotechnology news from FierceBiotech
NewsNanotech start-up offers 3D picture of a cell
Researchers at Washington University in St. Louis have launched a nanotech company --called PixelEXX Systems -- which intends to advance the use of nanoarrays in drug research. The founders say that Read more...
Nanotech investment will have payoff
A recent report by Credit Suisse analysts found that investing in medical nanotechnology could have a real payoff in the coming years. Oncology and CNS diseases in particular will be a target for Read more...
Emerging Drug Developer: Bind Biosciences Bind Biosciences hopes to get big on small tech Somewhere between leaving the top job at Acceleron Pharma and jumping onto the Read more... Ablynx plots IPO to advance nanobody pipeline
Belgium's Ablynx, which is developing a pipeline of Nanobody-based therapeutics, is planning to go public. There's no word on how big the offering is intended to be, but the biotech has raised close Read more...
Nanotech is promising, but faces hurdles
Nanotech is promising, but faces hurdles Dwight Seferos, PhD, a researcher at the International Institute for Nanotechnology at Northwestern University, held a sizable audience in thrall for nearly Read more...
Venture capitalists bet big on nanotechnology
Venture capitalists are always looking for the next big thing to invest in—and hopefully make loads of cash from. Several investors think they have found just the ticket. These VCs are homing in Read more...
FDA to address nanotechnology standards
Nanotechnology has enormous potential to revolutionize the drug, medical device, cosmetic and food industries, but according to a new report, the FDA lacks a standard regulatory procedure for Read more...
Korea blueprints $14.3B biotech investment planKorea's government has unveiled plans to invest $14.3 billion into the country's biotech industry to support research and commercialization efforts. Korea's goal is to push the biotech industry to become a $60 billion market by 2016. The government wants to integrate biotech work with advances in genomics, information technology and nanotechnology. There are also plans to provide clear ethical oversight to make sure there's no repeat of the recent … Read more...ALSO NOTED: Memory suspends trial; FDA rejects Cytomedix claim;and much more...> Memory Pharmaceuticals has suspended a midstage trial of its Alzheimer's therapy as it addresses the FDA's request for more information on revisions to toxicology reports. Report > The FDA has rejected Cytomedix's claim that its AutoloGel wound healing gel is equivalent to similar therapies on the market. Report > Dr. Mauro … Read more...FDA cautioned to better regulate nanomaterialsA public hearing called by the FDA turned into a forum to criticize the agency for what was described as a lax attitude toward regulating the nanomaterials being used in new therapies and consumer products. Some of the FDA's harshest critics say that the FDA has become a cheerleader for nanotechnology instead of a watchdog for potentially hazardous products. Others noted that a variety of nanobio products have been incorporated into new therapies with little or nothing being done to track … Read more... | Press ReleasesPRESS RELEASE: New nanoparticle vaccine is more effective but less expensive New nanoparticle vaccine is more effective but less expensive Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a Read more... |
Get more nanotechnology coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets